Charles River Laboratories (CRL) — Capital Reinvestment Ratio
Charles River Laboratories (CRL) has a Capital Reinvestment Ratio of 0.17x as of June 2026, meaning it reinvests 0% of its operating cash flow ($179.72 Million) in capital expenditures ($31.11 Million). Check tangible equity quality of Charles River Laboratories to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Charles River Laboratories Capital Reinvestment Ratio (1998–2025)
This chart tracks Charles River Laboratories's Capital Reinvestment Ratio across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Charles River Laboratories.
Annual Capital Reinvestment Ratio for Charles River Laboratories (1998–2025)
Year-by-year Capital Reinvestment Ratio for Charles River Laboratories from 1998 to 2025. See Charles River Laboratories free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | $737.65 Million | $219.15 Million | ▼ -6.3% |
| 2024 | 0.32x | $734.58 Million | $232.97 Million | ▼ -31.9% |
| 2023 | 0.47x | $683.90 Million | $318.53 Million | ▼ -11.1% |
| 2022 | 0.52x | $619.64 Million | $324.73 Million | ▲ +74.3% |
| 2021 | 0.30x | $760.80 Million | $228.77 Million | ▼ -1.3% |
| 2020 | 0.30x | $546.58 Million | $166.56 Million | ▲ +4.3% |
| 2019 | 0.29x | $480.94 Million | $140.51 Million | ▼ -8.0% |
| 2018 | 0.32x | $441.14 Million | $140.05 Million | ▲ +21.8% |
| 2017 | 0.26x | $316.26 Million | $82.43 Million | ▲ +40.6% |
| 2016 | 0.19x | $298.32 Million | $55.29 Million | ▼ -16.1% |
| 2015 | 0.22x | $286.36 Million | $63.25 Million | ▼ -2.6% |
| 2014 | 0.23x | $251.05 Million | $56.92 Million | ▲ +20.0% |
| 2013 | 0.19x | $207.14 Million | $39.15 Million | ▼ -17.3% |
| 2012 | 0.23x | $207.90 Million | $47.53 Million | ▼ -4.5% |
| 2011 | 0.24x | $205.28 Million | $49.14 Million | ▼ -5.6% |
| 2010 | 0.25x | $169.01 Million | $42.86 Million | ▼ -28.7% |
| 2009 | 0.36x | $225.04 Million | $80.01 Million | ▼ -49.5% |
| 2008 | 0.70x | $279.95 Million | $197.08 Million | ▼ -11.9% |
| 2007 | 0.80x | $284.25 Million | $227.04 Million | ▼ -27.8% |
| 2006 | 1.11x | $164.37 Million | $181.75 Million | ▲ +173.9% |
| 2005 | 0.40x | $236.70 Million | $95.55 Million | ▲ +64.6% |
| 2004 | 0.25x | $184.83 Million | $45.34 Million | ▼ -7.2% |
| 2003 | 0.26x | $123.77 Million | $32.70 Million | ▼ -5.9% |
| 2002 | 0.28x | $133.66 Million | $37.54 Million | ▼ -45.4% |
| 2001 | 0.51x | $71.30 Million | $36.66 Million | ▲ +11.5% |
| 2000 | 0.46x | $33.77 Million | $15.56 Million | ▲ +33.7% |
| 1999 | 0.34x | $37.57 Million | $12.95 Million | ▲ +8.2% |
| 1998 | 0.32x | $37.38 Million | $11.91 Million | — |